In this Swisspreneur Briefing, Sophie Lamparter, Founding Partner at Vitamin°C, and Laurent Decrue, Co-Founder and Co-CEO of Holycode, join Silvan to look back at an unusually active summer for Swiss startups. After a weaker first half of the year, August brought several rounds that felt much larger than what the ecosystem is used to seeing.
The discussion starts with Gravis Robotics’ CHF 200M Series A and what it says about physical AI, ambition, and the old Swiss habit of selling too early. Sophie and Laurent also look at SWISSto12’s CHF 70M Series C and Adaptyv Bio’s CHF 40M Series A, asking what these cases reveal about deeptech, commercial traction, and the kind of capital needed to scale.
The episode then widens into a bigger question for the Swiss ecosystem. Switzerland has the talent and the technology. The challenge is whether enough capital, operator experience and ambition can come together to turn more of these companies into global champions. The conversation also touches on the future of SaaS, the rise of AI-native software, and why the next phase of startup growth may look very different from the last one.
Podden och tillhörande omslagsbild på den här sidan tillhör
Swisspreneur. Innehållet i podden är skapat av Swisspreneur och inte av,
eller tillsammans med, Poddtoppen.